Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.34M | 1.78M | 1.55M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.34M | 1.78M | 1.55M | -- | -- |
| Cost of Revenue | 46.00K | 14.00K | -- | -- | -- |
| Gross Profit | 2.30M | 1.77M | 1.55M | -- | -- |
| SG&A Expenses | 64.46M | 50.67M | 45.58M | 40.70M | 38.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.72M | 67.06M | 63.69M | 57.23M | 55.02M |
| Operating Income | -78.38M | -65.28M | -62.14M | -57.23M | -55.02M |
| Income Before Tax | -84.01M | -68.36M | -63.06M | -58.01M | -55.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -84.01 | -68.36 | -63.06 | -58.01 | -55.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.01M | -68.36M | -63.06M | -58.01M | -55.53M |
| EBIT | -78.38M | -65.28M | -62.14M | -57.23M | -55.02M |
| EBITDA | -78.21M | -65.14M | -62.03M | -57.13M | -54.91M |
| EPS Basic | -0.69 | -0.68 | -0.80 | -0.82 | -0.84 |
| Normalized Basic EPS | -0.43 | -0.43 | -0.50 | -0.51 | -0.52 |
| EPS Diluted | -0.69 | -0.68 | -0.80 | -0.82 | -0.84 |
| Normalized Diluted EPS | -0.43 | -0.43 | -0.50 | -0.51 | -0.52 |
| Average Basic Shares Outstanding | 471.51M | 399.20M | 335.20M | 295.43M | 265.13M |
| Average Diluted Shares Outstanding | 471.51M | 399.20M | 335.20M | 295.43M | 265.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |